Author

Hong-Bing Liu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Efficacy and safety of third-generation EGFR-TKI rechallenge therapy in advanced non-small cell lung cancer patients with EGFR mutation: a retrospective cohort study

Background Third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have become the standard treatment for EGFR-mutant non-small cell lung cancer (NSCLC), but acquired resistance remains inevitable. Current post-progression salvage regimens offer only modest clinical benefits, leaving...

Jia-Jie Sun, Xin-Jing Li, Bing-Xue Wang et al. · Translational Lung Cancer Re... · 0 citations

Open access Sep 2026

Initiation of immune checkpoint inhibitor therapy in winter is associated with improved overall survival in patients with advanced non-small cell lung cancer

Immune checkpoint inhibitors (ICIs), targeting programmed cell death protein 1, programmed death-ligand 1 and cytotoxic T-lymphocyte-associated protein 4, have become a standard treatment resulting in improved outcomes in advanced non-small cell lung cancer (NSCLC); however, the influence of seasonal variations on trea...

Zhang-Xuan Chen, Jing-Si Chen, Yang Yao et al. · Oncology Letters · 0 citations